5. Arrhythmias are the most common cause of cardiac syncope, but structural cardiovascular disease can also cause syncope in some circumstances.
6. There is a bimodal distribution of patient age on presentation: in adolescents and young adults a reflex mechanism is the most common and above the age of 65 a cardiac cause or orthostatic hypotension should be suspected. -Patients with high risk criteria require prompt hospitalization or intensive evaluation.
The initial evaluation after T-LOC consists of:

In low risk patients the degree of investigation depends on the frequency of syncope and its impact on quality of life. In those low risk patients with T-LOC of unknown origin and frequent recurrences, either a strategy consisting on early implant of a loop recorder and wait for new T-LOC or to perform cardiac or neurally mediated
tests, can be followed.
11.
The principal goals of treatment for patients with syncope are to prolong survival, mainly by decreasing the risk of sudden cardiac death, limit physical injuries, and prevent recurrences. The importance and priority of these different goals depend on the cause of syncope.
Evaluation of T-LOC should ideally be performed by Syncope Management Units:
The main objectives of such units are to provide state-of-the-art guideline-based assessment of symptomatic patients, in order to risk-stratify them, obtain an accurate aetiological diagnosis and assess prognosis.
The literature on syncope evaluation and treatment is largely composed of case
series, cohort studies, or retrospective analyses of already existing data.
2. The impact of these approaches on guiding therapy and reducing syncope recurrences is difficult to discern without randomization and blinding. For some of the recommendations related to diagnostic processes, controlled trials have never been performed.
3. Consequently, some of these recommendations are based on brief observational studies, accepted clinical practice, expert consensus and sometimes common sense.
In those cases, according to the current format of recommendations, a level of evidence C is given. 
Disclaimer:
The ESC Guidelines represent the views of the ESC which were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgment. The guidelines do not, however, override the individual responsibility of health professionals to make appropriate decisions in the circumstances of the individual patients, in consultation with that patient, and where appropriate and necessary the patient' s guardian or carer. It is also the health professional' s responsibility to verify the rules and regulations applicable to drugs and devices at the time of prescription.
